Trials / Recruiting
RecruitingNCT05870111
Citicoline in Youth Alcohol Use Disorder
Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 16 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Citicoline (cytidine diphosphate-choline) | 2000mg/day citicoline, administered orally, for 4 weeks |
| DRUG | Placebo oral capsule | placebo capsule daily for 4 weeks, matched in appearance to citicoline to preserve double-blind, administered orally |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2029-02-01
- Completion
- 2029-02-01
- First posted
- 2023-05-23
- Last updated
- 2025-10-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05870111. Inclusion in this directory is not an endorsement.